نتایج جستجو برای: nanotherapy

تعداد نتایج: 174  

Journal: :Molecular cancer therapeutics 2015
Deepti Soodgupta Dipanjan Pan Grace Cui Angana Senpan Xiaoxia Yang Lan Lu Katherine N Weilbaecher Edward V Prochownik Gregory M Lanza Michael H Tomasson

UNLABELLED Multiple myeloma pathogenesis is driven by the MYC oncoprotein, its dimerization with MAX, and the binding of this heterodimer to E-Boxes in the vicinity of target genes. The systemic utility of potent small molecule inhibitors of MYC-MAX dimerization was limited by poor bioavailability, rapid metabolism, and inadequate target site penetration. We hypothesized that new lipid-based MY...

2013
Shengli Dong Qibin Tang Miaoyun Long Jian Guan Lu Ye Gaopeng Li

BACKGROUND/AIM A local nanotherapy (LNT) combining the therapeutic efficacy of trans-arterial embolization, nanoparticles, and p53 gene therapy has been previously presented. The study presented here aimed to further improve the incomplete tumor eradication and limited survival enhancement and to elucidate the molecular mechanism of the LNT. METHODS In a tumor-targeting manner, recombinant ex...

2013
Thomas S.C. Ng David Wert Hargun Sohi Daniel Procissi David Colcher Andrew A. Raubitschek Russell E. Jacobs

Purpose: Targeted nanotherapies are being developed to improve tumor drug delivery and enhance therapeutic response. Techniques that can predict response will facilitate clinical translation and may help define optimal treatment strategies. We evaluated the efficacy of diffusion-weighted magnetic resonance imaging tomonitor early response to CRLX101 (a cyclodextrin-based polymer particle contai...

2015
Sonja Rittchen Amanda Boyd Alasdair Burns Jason Park Tarek M. Fahmy Su Metcalfe Anna Williams

Multiple sclerosis (MS) is a progressive demyelinating disease of the central nervous system (CNS). Many nerve axons are insulated by a myelin sheath and their demyelination not only prevents saltatory electrical signal conduction along the axons but also removes their metabolic support leading to irreversible neurodegeneration, which currently is untreatable. There is much interest in potentia...

2012
Huansheng Dong Tarek M. Fahmy Su M. Metcalfe Steve L. Morton Xiao Dong Luca Inverardi David B. Adams Wenda Gao Hongjun Wang

Two major hurdles need to be surmounted for cell therapy for diabetes: (i) allo-immune rejection of grafted pancreatic islets, or stem/precursor cell-derived insulin-secreting cells; and (ii) continuing auto-immunity against the diabetogenic endogenous target antigen. Nanotherapeutics offer a novel approach to overcome these problems and here we ask if creation of "stealth" islets encapsulated ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید